Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD

42.98

-0.12 (-0.28%)

At close: Sep 11, 2026, 4:00 PM EDT

43.66

+0.68 (1.58%)

Pre-market: Sep 14, 2026, 7:04 AM EDT

Boston Scientific Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	20,996	20,074	16,747	14,240	12,682	11,888
Revenue Growth	13.53%	19.87%	17.61%	12.29%	6.68%	19.92%
Gross Profit	14,527	13,807	11,457	9,849	8,679	8,128
Operating Income	4,298	3,971	3,002	2,417	2,033	1,824
Net Income	3,674	2,898	1,853	1,570	642	985
Earnings Per Share	2.47	1.94	1.25	1.07	0.45	0.69
EPS Growth	46.89%	55.20%	16.82%	138.42%	-34.96%	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
MedSurg	7,050	6,824	5,993	5,422	4,911	4,633
Cardiovascular	13,947	13,250	10,755	8,819	7,831	7,242
Revenue (Total)	20,996	20,074	16,747	14,240	12,682	11,888

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	539	1,965	414	865	928	1,925
Total Debt	12,624	11,972	11,228	9,568	9,343	9,525
Net Cash (Debt)	-12,085	-10,007	-10,814	-8,703	-8,415	-7,600
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.11	-6.70	-7.28	-5.95	-5.84	-5.30

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4,529	4,534	3,435	2,503	1,526	1,870
Capital Expenditures	-904	-876	-790	-711	-588	-554
Free Cash Flow	3,625	3,658	2,645	1,792	938	1,316
Free Cash Flow Growth	4.02%	38.30%	47.60%	91.05%	-28.72%	16.25%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	69.19%	68.78%	68.41%	69.16%	68.44%	68.37%
Operating Margin	20.47%	19.78%	17.93%	16.97%	16.03%	15.34%
Pretax Margin	18.39%	16.86%	13.62%	13.94%	9.00%	9.06%
Profit Margin	17.50%	14.44%	11.06%	11.03%	5.06%	8.29%
FCF Margin	17.27%	18.22%	15.79%	12.58%	7.40%	11.07%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.41	48.78	71.04	53.94	103.23	61.46
Forward PE	13.11	28.71	33.08	26.76	24.51	23.73
P/FCF Ratio	17.18	38.64	49.77	47.26	70.65	46.00
PS Ratio	2.97	7.04	7.86	5.95	5.23	5.09